Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

1,521 questions in 132 reviews · Hepato-Biliary

current versions
No studies 303 · 19.9%Ungraded 39 · 2.6%Very low 876 · 57.6%Low 216 · 14.2%Moderate 65 · 4.3%High 22 · 1.4%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
LC + LCBDE vs pre‐operative ERCP + LC
Mortality at 30 days · with common bile duct stones
Surgical versus endoscopic treatment of bile duct stones (2013) · Cochrane
OR 0.72 [0.12, 4.33]5 studies · 580 participantsModerate
LC + LCBDE vs pre‐operative ERCP + LC
Total morbidity · with common bile duct stones
Surgical versus endoscopic treatment of bile duct stones (2013) · Cochrane
OR 1.28 [0.8, 2.05]5 studies · 580 participantsModerate
LC + LCBDE vs pre‐operative ERCP + LC
Failure of procedure · with common bile duct stones
Surgical versus endoscopic treatment of bile duct stones (2013) · Cochrane
OR 0.51 [0.16, 1.59]5 studies · 580 participantsModerate
LC + LCBDE vs pre‐operative ERCP + LC
Retained stones after primary intervention · with common bile duct stones
Surgical versus endoscopic treatment of bile duct stones (2013) · Cochrane
OR 0.79 [0.45, 1.39]5 studies · 580 participantsModerate
LC + LCBDE vs pre‐operative ERCP + LC
Conversion to open surgery · with common bile duct stones
Surgical versus endoscopic treatment of bile duct stones (2013) · Cochrane
OR 1.46 [0.76, 2.81]5 studies · 580 participantsModerate
Intervention NR
Variceal bleeding 5 years · patients with chronic hepatitis C who have failed prior antiviral therapy and who have severe histologic disease…
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Ascites 5 years · patients with chronic hepatitis C who have failed prior antiviral therapy and who have severe histologic disease…
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C (2013) · Cochrane
no estimate extractedNRNo studies
Early vs delayed laparoscopic cholecystectomy
Mortality · people with acute cholecystitis.
Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis (2013) · Cochrane
no estimate extracted5 studies · 438 participantsVery low
Early vs delayed laparoscopic cholecystectomy
Bile duct injury · people with acute cholecystitis.
Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis (2013) · Cochrane
Peto OR 0.49 [0.05, 4.72]5 studies · 438 participantsVery low
Early vs delayed laparoscopic cholecystectomy
Other serious complications · people with acute cholecystitis.
Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis (2013) · Cochrane
RR 1.29 [0.61, 2.72]5 studies · 438 participantsVery low
Early vs delayed laparoscopic cholecystectomy
Conversion to open cholecystectomy · people with acute cholecystitis.
Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis (2013) · Cochrane
RR 0.89 [0.63, 1.25]6 studies · 488 participantsVery low
Early vs delayed laparoscopic cholecystectomy
Hospital stay · people with acute cholecystitis.
Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis (2013) · Cochrane
no estimate extracted4 studies · 373 participantsModerate
Early vs delayed laparoscopic cholecystectomy
Operating time · people with acute cholecystitis.
Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis (2013) · Cochrane
no estimate extracted6 studies · 488 participantsModerate
Early vs delayed laparoscopic cholecystectomy
Return to work · people with acute cholecystitis.
Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis (2013) · Cochrane
no estimate extracted1 study · 36 participantsVery low
T‐tube drainage vs primary closure
Peri‐operative mortality · patients undergoing open common bile duct exploration.
T‐tube drainage versus primary closure after open common bile duct exploration (2013) · Cochrane
RR 2.25 [0.55, 9.25]6 studies · 359 participantsVery low
T‐tube drainage vs primary closure
Serious morbidity (rate) · patients undergoing open common bile duct exploration.
T‐tube drainage versus primary closure after open common bile duct exploration (2013) · Cochrane
Rate ratio 2.19 [0.98, 4.91]4 studies · 272 participantsVery low
T‐tube drainage vs primary closure
Serious morbidity (proportion) · patients undergoing open common bile duct exploration.
T‐tube drainage versus primary closure after open common bile duct exploration (2013) · Cochrane
RR 2.53 [0.29, 21.98]1 study · 35 participantsVery low
T‐tube drainage vs primary closure
Operating time · patients undergoing open common bile duct exploration.
T‐tube drainage versus primary closure after open common bile duct exploration (2013) · Cochrane
no estimate extracted1 study · 40 participantsVery low
T‐tube drainage vs primary closure
Hospital stay · patients undergoing open common bile duct exploration.
T‐tube drainage versus primary closure after open common bile duct exploration (2013) · Cochrane
no estimate extracted5 studies · 333 participantsVery low
T‐tube drainage vs primary closure after laparoscopic common bile duct exploration
Serious morbidity (rate) · laparoscopic common bile duct exploration.
T‐tube drainage versus primary closure after laparoscopic common bile duct exploration (2013) · Cochrane
Rate ratio 1.59 [0.66, 3.83]3 studies · 295 participantsVery low
T‐tube drainage vs primary closure after laparoscopic common bile duct exploration
Serious morbidity (proportion of patients) · laparoscopic common bile duct exploration.
T‐tube drainage versus primary closure after laparoscopic common bile duct exploration (2013) · Cochrane
RR 1.86 [0.87, 3.96]3 studies · 295 participantsVery low
T‐tube drainage vs primary closure after laparoscopic common bile duct exploration
Operating time (minutes) · laparoscopic common bile duct exploration.
T‐tube drainage versus primary closure after laparoscopic common bile duct exploration (2013) · Cochrane
no estimate extracted3 studies · 295 participantsVery low
T‐tube drainage vs primary closure after laparoscopic common bile duct exploration
Hospital stay (days) · laparoscopic common bile duct exploration.
T‐tube drainage versus primary closure after laparoscopic common bile duct exploration (2013) · Cochrane
no estimate extracted3 studies · 295 participantsVery low
Routine abdominal drain vs 'no drain'
Mortality · patients with laparoscopic cholecystectomy.
Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystectomy (2013) · Cochrane
RR 0.41 [0.04, 4.37]10 studies · 1681 participantsVery low
Routine abdominal drain vs 'no drain'
Serious adverse events (proportion of patients) · patients with laparoscopic cholecystectomy.
Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystectomy (2013) · Cochrane
RR 2.12 [0.67, 6.4]7 studies · 1143 participantsVery low
Routine abdominal drain vs 'no drain'
Serious adverse events (number of events) · patients with laparoscopic cholecystectomy.
Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystectomy (2013) · Cochrane
rate ratio 1.6 [0.66, 3.87]8 studies · 1286 participantsVery low
Routine abdominal drain vs 'no drain'
Quality of life Psychosocial Adjustment To Illness Scale Self‐Report version (PAIS‐SR) · patients with laparoscopic cholecystectomy.
Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystectomy (2013) · Cochrane
no estimate extracted1 study · 93 participantsVery low
Routine abdominal drain vs 'no drain'
Same day discharge · patients with laparoscopic cholecystectomy.
Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystectomy (2013) · Cochrane
RR 0.05 [0, 0.75]1 study · 68 participantsVery low
Routine abdominal drain vs 'no drain'
Hospital stay · patients with laparoscopic cholecystectomy.
Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystectomy (2013) · Cochrane
no estimate extracted4 studies · 419 participantsVery low
Routine abdominal drain vs 'no drain'
Operating time · patients with laparoscopic cholecystectomy.
Routine abdominal drainage versus no abdominal drainage for uncomplicated laparoscopic cholecystectomy (2013) · Cochrane
no estimate extracted6 studies · 745 participantsVery low
Intervention NR
Interferon vs. control · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
90‐day mortality · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
RR 1.31 [0.41, 4.19]1 study · 81 participantsVery low
Intervention NR
Mortality at maximal · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
RR 0.86 [0.36, 2.08]2 studies · 105 participantsVery low
Intervention NR
Mortality (HR) · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
HR 0.45 [0.13, 1.56]1 study · 81 participantsVery low
Intervention NR
HCV antibody vs. placebo · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Interferon vs. control · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Retransplantation at maximal · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
RR 1.17 [0.22, 6.2]2 studies · 105 participantsVery low
Intervention NR
HCV antibody vs. placebo · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
no estimate extractedNRNo studies
Intervention NR
90‐day retransplantation · patients undergoing liver transplantation for chronic hepatitis C viral infection.
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver… (2013) · Cochrane
RR 1.71 [0.09, 32.93]1 study · 18 participantsVery low
Intervention NR
Serious adverse events · patients undergoing laparoscopic cholecystectomy.
Abdominal lift for laparoscopic cholecystectomy (2013) · Cochrane
Rate ratio 1 [0.17, 5.77]2 studies · 58 participantsVery low
Intervention NR
Operating time · patients undergoing laparoscopic cholecystectomy.
Abdominal lift for laparoscopic cholecystectomy (2013) · Cochrane
no estimate extracted4 studies · 107 participantsVery low
Intervention NR
Serious adverse events (number of serious adverse events) · patients with laparoscopic cholecystectomy.
Abdominal lift for laparoscopic cholecystectomy (2013) · Cochrane
Rate ratio 1.73 [0.35, 8.61]3 studies · 198 participantsVery low
Intervention NR
Serious adverse events (proportion of patients with serious adverse events) · patients with laparoscopic cholecystectomy.
Abdominal lift for laparoscopic cholecystectomy (2013) · Cochrane
RR 2.01 [0.52, 7.8]6 studies · 343 participantsVery low
Intervention NR
Conversion to open cholecystectomy · patients with laparoscopic cholecystectomy.
Abdominal lift for laparoscopic cholecystectomy (2013) · Cochrane
RR 0.76 [0.26, 2.21]11 studies · 460 participantsVery low
Intervention NR
Operating time · patients with laparoscopic cholecystectomy.
Abdominal lift for laparoscopic cholecystectomy (2013) · Cochrane
no estimate extracted16 studies · 649 participantsVery low
Intervention NR
Proportion discharged as day‐patient laparoscopic cholecystectomy · patients with laparoscopic cholecystectomy.
Abdominal lift for laparoscopic cholecystectomy (2013) · Cochrane
RR 1.67 [0.85, 3.26]2 studies · 62 participantsVery low
Intervention NR
Operating time · surgical trainees training in laparoscopic surgery.
Virtual reality training for surgical trainees in laparoscopic surgery (2013) · Cochrane
no estimate extracted3 studies · 49 participantsVery low
Intervention NR
Operative performance · surgical trainees training in laparoscopic surgery.
Virtual reality training for surgical trainees in laparoscopic surgery (2013) · Cochrane
no estimate extracted2 studies · 33 participantsVery low
Day‐surgery vs overnight stay surgery
Short term mortality · patients with laparoscopic cholecystectomy.
Day‐surgery versus overnight stay surgery for laparoscopic cholecystectomy (2013) · Cochrane
no estimate extracted1 study · 86 participantsLow
Day‐surgery vs overnight stay surgery
Serious adverse events · patients with laparoscopic cholecystectomy.
Day‐surgery versus overnight stay surgery for laparoscopic cholecystectomy (2013) · Cochrane
Rate Ratio 3.24 [0.74, 14.09]4 studies · 391 participantsVery low